rs121965023
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM2_SupportingPP4PM3_SupportingPVS1_Strong
This summary comes from the ClinGen Evidence Repository: The NM_000203.5:c.928C>T (p.Gln310Ter) variant in IDUA is a nonsense variant predicted to cause a premature stop codon in biologically-relevant exon 7 out of 14, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. However, RT-PCR product showed a "doublet" with an upper band slightly larger than the normal band (505bp). Part of the mRNA was spliced from intron 5 to include 28nt of intronic sequence, indicating use of a cryptic splice site. This alternative splicing was said to create a frameshift and an open reading frame until exon 9. Since RT-PCR appears to show a near complete proportion of alternatively spliced transcript, the strength of PVS1 was reduced by 1 level to strong (PVS1_Strong; PMID:8328452). This variant has been detected in at least 1 individual with MPS I. This individual was homozygous for the variant (PMID:8328452; PM3_Supporting). At least 1 patient with this variant had clinical features specific to MPS I including dysostosis multiplex, corneal opacities, hepatosplenomegaly, and arthropathy (PMID:8328452; PP4). The highest population minor allele frequency in gnomAD v4.0. is 0.0000008630 (1/1158762 alleles) in the European non-Finnish population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025), meeting this criterion (PM2_Supporting). To our knowledge, the results of functional assays have not been reported for this variant. There is a ClinVar entry for this variant (Variation ID: 11915, 0 star review status) with 1 submitter classifying the variant as pathogenic; however this submitter is OMIM. In summary, this variant meets the criteria to be classified as likely pathogenic for MPS I based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (Specifications Version 1.0.0): PVS1_Strong, PM3_Supporting, PP4, PM2_Supporting.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on March 3, 2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA256115/MONDO:0001586/091
Frequency
Consequence
NM_000203.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- mucopolysaccharidosis type 1Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Scheie syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- Hurler syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Hurler-Scheie syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IDUA | TSL:2 MANE Select | c.928C>T | p.Gln310* | stop_gained | Exon 7 of 14 | ENSP00000425081.2 | P35475-1 | ||
| IDUA | TSL:1 | c.928C>T | p.Gln310* | stop_gained | Exon 7 of 14 | ENSP00000247933.4 | P35475-1 | ||
| IDUA | c.1003C>T | p.Gln335* | stop_gained | Exon 8 of 15 | ENSP00000632448.1 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 7.05e-7 AC: 1AN: 1418258Hom.: 0 Cov.: 35 AF XY: 0.00000143 AC XY: 1AN XY: 701350 show subpopulations
GnomAD4 genome Cov.: 34
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at